icd10free.comPowered by Curo

ICD-10 Coding for Myeloproliferative Neoplasms(D47.3, D75.1, D75.81)

Save

Explore ICD-10 coding for Myeloproliferative Neoplasms, including Polycythemia Vera and Essential Thrombocythemia, with detailed documentation requirements.

Also known as:
MPNChronic Myeloproliferative Disorders
Related ICD-10 Code Ranges

Complete code families applicable to Myeloproliferative Neoplasms

C00-D49Primary Range

Neoplasms

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
D47.3Essential Thrombocythemia
Primary ICD-10-CM Codes
Essential (hemorrhagic) thrombocythemia
D47.3Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Secondary polycythemiaD75.1
Reactive thrombocytosisD75.81

Documentation & Coding Risks

Avoid these common issues when documenting Myeloproliferative Neoplasms.

Failing to document mutation status

Impact

Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation

Ensure all genetic test results are documented.

Using unspecified codes when specific mutations are confirmed

Impact

Reimbursement: May lead to denied claims or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.

Mitigation

Always use specific codes like D45.0 or D47.3 when mutations are confirmed.

Genetic Testing Documentation

Impact

Lack of documentation for genetic testing results.

Mitigation

Ensure all test results are included in the patient's record.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with D47.3.